Holding the inflammatory system in check: NLRs keep it cool

F1000Prime Reports

Volumn 7, Issue , 2015, Pages

  Jha, Sushmita ^a   Ting, Jenny Pan Yun ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY JODHPUR   (India)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR;

ARTICLE; HUMAN; INFECTION; INFLAMMATION; NEOPLASM; NONHUMAN; PATTERN RECOGNITION;

EID: 84922342045     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P7-15     Document Type: Article

References (87)

1. Harton JA, Linhoff MW, Zhang J, Ting JP: Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. Journal of immunology (Baltimore, Md.: 1950) 2002, 169:4088-93.
2. van der Hilst, JCH, Simon A, Drenth, JPH: Hereditary periodic fever and reactive amyloidosis. Clinical and experimental medicine 2005, 5:87-98.
3. Lequerré T, Vittecoq O, Saugier-Veber P, Goldenberg A, Patoz P, Frébourg T, Le Loët X: A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology (Oxford, England) 2007, 46:709-14.
4. Koné-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I: Autoinflammatory gene mutations in Behçet's disease. Annals of the rheumatic diseases 2007, 66:832-4.
5. Brydges SD, Mueller JL, McGeough M.D., Pena CA, Misaghi A, Gandhi C, Putnam C.D., Boyle DL, Firestein GS, Horner AA, Soroosh P, Watford W.T., O'Shea JJ, Kastner DL, Hoffman HM: Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 2009, 30:875-87.
6. Boschan C, Witt O, Lohse P., Foeldvari I, Zappel H, Schweigerer L: Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. American journal of medical genetics Part A 2006, 140:883-6.
7. Ting JP, Kastner DL, Hoffman HM: CATERPILLERs, pyrin and hereditary immunological disorders. Nature reviews Immunology 2006, 6:183-95.
8. Ting JP, Davis BK: CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annual review of immunology 2005, 23:387-414.
9. Hugot JP, Chamaillard M, Zouali H., Lesage S, Cézard JP, Belaiche J., Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
10. Ogura Y, Bonen DK, Inohara N, Nicolae D.L., Chen FF, Ramos R, Britton H, Moran T., Karaliuskas R, Duerr RH, Achkar J.P., Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001,411:603-6.
11. Hoffman HM, Mueller JL, Broide D.H., Wanderer AA, Kolodner RD: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature genetics 2001, 29:301-5.
12. Dodé C, Le Dû N, Cuisset L, Letourneur F, Berthelot J, Vaudour G, Meyrier A, Watts RA, Scott, David GI, Nicholls A, Granel B, Frances C, Garcier F, Edery P, Boulinguez S, Domergues J, Delpech M, Grateau G: New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. American journal of human genetics 2002, 70:1498-506.
13. Jin Y, Mailloux CM, Gowan K, Riccardi S.L., LaBerge G., Bennett DC, Fain PR, Spritz RA: NALP1 in vitiligo-associated multiple autoimmune disease. The New England journal of medicine 2007, 356:1216-25.
14. Lokuta MA, Cooper KM, Aksentijevich I, Kastner D.L., Huttenlocher A: Neutrophil chemotaxis in a patient with neonatal-onset multisystem inflammatory disease and Muckle-Wells syndrome. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 2005, 95:394-9.
15. Ting JP, Lovering RC, Alnemri E.S., Bertin J., Boss JM, Davis BK, Flavell RA, Girardin S.E., Godzik A., Harton JA, Hoffman HM, Hugot J, Inohara N., Mackenzie A, Maltais LJ, Nunez G, Ogura Y, Otten LA, Philpott D, Reed JC, Reith W, Schreiber S, Steimle V, Ward PA: The NLR gene family: a standard nomenclature. Immunity 2008, 28:285-7.
16. Zhao Y, Yang J, Shi J., Gong Y, Lu Q, Xu H., Liu L, Shao F: The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011, 477:596-600.
17. Kofoed EM, Vance RE: Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011, 477:592-5.
18. Mo J, Boyle JP, Howard C.B., Monie TP, Davis BK, Duncan JA: Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. The Journal of biological chemistry 2012, 287:23057-67.
19. Halff EF, Diebolder CA, Versteeg M, Schouten A., Brondijk, T Harma C, Huizinga EG: Formation and structure of a NAIP5-NLRC4 inflammasome induced by direct interactions with conserved N- and C-terminal regions of flagellin. The Journal of biological chemistry 2012, 287:38460-72.
20. Hong M, Yoon S, Wilson IA: Structure and functional characterization of the RNA-binding element of the NLRX1 innate immune modulator. Immunity 2012, 36:337-47.
21. Ogura Y, Sutterwala FS, Flavell RA: The inflammasome: first line of the immune response to cell stress. Cell 2006, 126:659-62.
22. Allen IC, Wilson JE, Schneider M, Lich J.D., Roberts RA, Arthur JC, Woodford RT, Davis B.K., Uronis JM, Herfarth HH, Jobin C, Rogers A.B., Ting JP: NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kB signaling. Immunity 2012, 36:742-54.
23. Lich JD, Williams KL, Moore C.B., Arthur JC, Davis BK, Taxman DJ, TingJP: Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. Journal of immunology (Baltimore, Md.: 1950) 2007, 178:1256-60.
24. Zaki MH, Vogel P, Malireddi, RK Subbarao, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti T: The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer cell 2011, 20:649-60.
25. Conti BJ, Davis BK, Zhang J, O'connor W, Williams KL, Ting JP: CATERPILLER 16.2 (CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function. The Journal of biological chemistry 2005, 280:18375-85.
26. Zhang L, Mo J, Swanson K.V., Wen H., Petrucelli A, Gregory SM, Zhang Z, Schneider M., Jiang Y, Fitzgerald KA, Ouyang S, Liu Z., Damania B, Shu H, Duncan JA, TingJP: NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING. Immunity 2014, 40:329-41.
27. Shiau CE, Monk KR, Joo W, Talbot WS: An anti-inflammatory NOD-like receptor is required for microglia development. Cell reports 2013, 5:1342-52.
28. Fiorentino L, Stehlik C, Oliveira V., Ariza ME, Godzik A, Reed JC: A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. The Journal of biological chemistry 2002, 277:35333-40.
29. Yao Y, Wang Y, Chen F., Huang Y, Zhu S, Leng Q., Wang H, Shi Y, Qian Y: NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens. Cell research 2012, 22:836-47.
30. Robbins GR, Truax AD, Davis B.K., Zhang L., Brickey WJ, Ting JP: Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins. The Journal of biological chemistry 2012, 287:24294-303.
31. Biswas A, Meissner TB, Kawai T, Kobayashi KS: Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator. Journal of immunology (Baltimore, Md.: 1950) 2012, 189:516-20.
32. Meissner TB, Li A, Biswas A., Lee K, Liu Y, Bayir E., Iliopoulos D, van den Elsen, Peter J, Kobayashi KS: NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:13794-9.
33. Staehli F, Ludigs K, Heinz L.X., Seguín-Estévez Q, Ferrero I, Braun M, Schroder K, Rebsamen M, Tardivel A, Mattmann C, MacDonald HR, Romero P, Reith W, Guarda G, Tschopp J: NLRC5 deficiency selectively impairs MHC class I-dependent lymphocyte killing by cytotoxic T cells. Journal of immunology (Baltimore, Md.: 1950) 2012, 188:3820-8.
34. Tong Y, Cui J, Li Q., Zou J, Wang HY, Wang R: Enhanced TLR-induced NF-kB signaling and type I interferon responses in NLRC5 deficient mice. Cell research 2012, 22:822-35.
35. Neerincx A, Rodriguez GM, Steimle V, Kufer TA: NLRC5 controls basal MHC class I gene expression in an MHC enhanceo-some-dependent manner. Journal of immunology (Baltimore, Md.: 1950) 2012, 188:4940-50.
36. Meissner TB, Liu Y, Lee K., Li A, Biswas A, van Eggermond, Marja CJA, van den Elsen, Peter J, Kobayashi KS: NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression. Journal of immunology (Baltimore, Md.: 1950) 2012, 188:4951-8.
37. Meissner TB, Li A, Liu Y., Gagnon E, Kobayashi KS: The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity. Biochemical and biophysical research communications 2012, 418:786-91.
38. Benko S, Magalhaes JG, Philpott D.J., Girardin SE: NLRC5 limits the activation of inflammatory pathways. Journal of immunology (Baltimore, Md.: 1950) 2010, 185:1681-91.
39. Cui J, Zhu L, Xia X., Wang HY, Legras X, Hong J, Ji J., Shen P, Zheng S, Chen Z.J., Wang R: NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 2010, 141:483-96.
40. Kuenzel S, Till A, Winkler M., Häsler R, Lipinski S., Jung S, Grötzinger J, Fickenscher H., Schreiber S, Rosenstiel P: The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. Journal of immunology (Baltimore, Md.: 1950) 2010, 184:1990-2000.
41. Neerincx A, Lautz K, Menning M., Kremmer E, Zigrino P, Hösel M, Büning H, Schwarzenbacher R., Kufer TA: A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. The Journal of biological chemistry 2010, 285:26223-32.
42. Kumar H, Pandey S, Zou J., Kumagai Y, Takahashi K, Akira S., Kawai T: NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections. Journal of immunology (Baltimore, Md.: 1950) 2011, 186:994-1000.
43. Davis BK, Roberts RA, Huang M.T., Willingham SB, Conti BJ, Brickey WJ, Barker B.R., Kwan M., Taxman DJ, Accavitti-Loper M, Duncan JA, TingJP: Cutting edge: NLRC5-dependent activation of the inflamma-some. Journal of immunology (Baltimore, Md.: 1950) 2011, 186:1333-7.
44. Triantafilou K, Kar S, van Kuppeveld, Frank JM, Triantafilou M: Rhinovirus-induced calcium flux triggers NLRP3 and NLRC5 activation in bronchial cells. American journal of respiratory cell and molecular biology 2013, 49:923-34.
45. Eitas TK, Chou W, Wen H., Gris D, Robbins GR, Brickey J, Oyama Y., Ting JP: The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation. The Journal of biological chemistry 2014, 289:4173-9.
46. Strober W, Asano N, Fuss I., Kitani A, Watanabe T: Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease. Immunological reviews 2014, 260:249-60.
47. Watanabe T, Asano N, Meng G., Yamashita K, Arai Y, Sakurai T., Kudo M, Fuss IJ, Kitani A, Shimosegawa T., Chiba T, Strober W: NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6. Mucosal immunology 2014, 7:1312-25.
48. Watanabe T, Asano N, Murray P.J., Ozato K., Tailor P, Fuss IJ, Kitani A, Strober W: Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. The Journal of clinical investigation 2008, 118:545-59.
49. Rosenzweig HL, Galster K, Vance E.E., Ensign-Lewis J, Nunez G, Davey M.P., Rosenbaum JT: NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice. Investigative ophthalmology & visual science 2011, 52:4106-12.
50. Petnicki-Ocwieja T, DeFrancesco AS, Chung E, Darcy C.T., Bronson RT, Kobayashi KS, Hu LT: Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PloS one 2011, 6:e17414.
51. Borm, MEA, van Bodegraven, AA, Mulder CJJ, Kraal G, Bouma G: The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype. Genes and immunity 2008, 9:274-8.
52. Franchi L, Amer A, Body-Malapel M, Kanneganti T., Ozören N, Jagirdar R., Inohara N, Vandenabeele P, Bertin J., Coyle A, Grant EP, Núñez G: Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1 beta in salmonella-infected macrophages. Nature immunology 2006, 7:576-82.
53. Lightfield KL, Persson J, Brubaker S.W., Witte CE, Moltke J von, Dunipace EA, Henry T, Sun Y, Cado D, Dietrich WF, Monack DM, Tsolis RM, Vance RE: Critical function for Naip5 in inflamma-some activation by a conserved carboxy-terminal domain of flagellin. Nature immunology 2008, 9:1171-8.
54. Miao EA, Alpuche-Aranda CM, Dors M., Clark AE, Bader MW, Miller SI, Aderem A: Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1 beta via Ipaf. Nature immunology 2006,7:569-75.
55. Miao EA, Ernst RK, Dors M, Mao D.P., Aderem A: Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2562-7.
56. Kanneganti T, Body-Malapel M, Amer A., Park J, Whitfield J, Franchi L., Taraporewala ZF, Miller D, Patton JT, Inohara N, Núñez G: Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. The Journal of biological chemistry 2006, 281:36560-8.
57. Kanneganti T, Ozören N, Body-Malapel M, Amer A, Park J., Franchi L, Whitfield J, Barchet W., Colonna M, Vandenabeele P, Bertin J, Coyle A, Grant EP, Akira S, Núñez G: Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440:233-6.
58. Williams KL, Lich JD, Duncan J.A., Reed W., Rallabhandi P, Moore C, Kurtz S., Coffield VM, Accavitti-Loper MA, Su L, Vogel S.N., Braunstein M., TingJP: The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. The Journal of biological chemistry 2005, 280:39914-24.
59. Zaki MH, Man SM, Vogel P, Lamkanfi M., Kanneganti T: Salmonella exploits NLRP 12-dependent innate immune signaling to suppress host defenses during infection. Proceedings of the National Academy of Sciences of the United States of America 2014, 111:385-90.
60. Allen IC, McElvania-TeKippe E, Wilson J.E., Lich JD, Arthur JC, Sullivan JT, Braunstein M, TingJPY: Characterization of NLRP 12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. PloS one 2013, 8:e60842.
61. Vladimer GI, Weng D, Paquette, Sara W Montminy, Vanaja SK, Rathinam, Vijay AK, Aune MH, Conlon JE, Burbage JJ, Proulx MK, Liu Q, Reed G, Mecsas JC, Iwakura Y, Bertin J, Goguen JD, Fitzgerald KA, Lien E: The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 2012, 37:96-107.
62. Ataide MA, Andrade WA, Zamboni D.S., Wang D., Souza Maria do Carmo, Franklin BS, Elian S, Martins FS, Pereira D, Reed G, Fitzgerald KA, Golenbock DT, Gazzinelli RT: Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS pathogens 2014, 10:e1003885.
63. Anand PK, Malireddi, RK Subbarao, Lukens JR, Vogel P, Bertin J, Lamkanfi M, Kanneganti T: NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012, 488:389-93.
64. Normand S, Delanoye-Crespin A, Bressenot A., Huot L, Grandjean T, Peyrin-Biroulet L, Lemoine Y., Hot D, Chamaillard M: Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:9601-6.
65. Chen GY, Liu M, Wang F., Bertin J, Núñez G: A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. Journal of immunology (Baltimore, Md.: 1950) 2011, 186:7187-94.
66. Elinav E, Strowig T, Kau A.L., Henao-Mejia J, Thaiss CA, Booth C.J., Peaper DR, Bertin J, Eisenbarth SC, Gordon J.I., Flavell RA: NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-57.
67. Grenier JM, Wang L, Manji G.A., Huang WJ, Al-Garawi A, Kelly R, Carlson A., Merriam S, Lora JM, Briskin M, DiStefano P.S., Bertin J: Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS letters 2002, 530:73-8.
68. Moore CB, Bergstralh DT, Duncan J.A., Lei Y., Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z., Lich JD, Heise MT, Chen Z, Ting JP: NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-7.
69. Xia X, Cui J, Wang H.Y., Zhu L., Matsueda S, Wang Q, Yang X., Hong J, Songyang Z, Chen Z.J., Wang R: NLRX1 negatively regulates TLR-induced NF-kB signaling by targeting TRAF6 and IKK. Immunity 2011, 34:843-53.
70. Allen IC, Moore CB, Schneider M, Lei Y., Davis BK, Scull MA, Gris D, Roney K.E., Zimmermann AG, Bowzard JB, Ranjan P, Monroe K.M., Pickles RJ, Sambhara S, Ting JPY: NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kB signaling pathways. Immunity 2011, 34:854-65.
71. Jaworska J, Coulombe F, Downey J., Tzelepis F, Shalaby K, Tattoli I., Berube J, Rousseau S, Martin J.G., Girardin SE, McCullers JA, Divangahi M: NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein. Proceedings of the National Academy of Sciences of the United States of America 2014, 111:E2110-9.
72. Rebsamen M, Vazquez J, Tardivel A., Guarda G, Curran J, Tschopp J: NLRX1/NOD5 deficiency does not affect MAVS signalling. Cell death and differentiation 2011, 18:1387.
73. Scherz-Shouval R, Elazar Z: Regulation of autophagy by ROS: physiology and pathology. Trends in biochemical sciences 2011, 36:30-8.
74. Lei Y, Wen H, Yu Y., Taxman DJ, Zhang L, Widman DG, Swanson K.V., Wen K., Damania B, Moore CB, Giguère PM, Siderovski D.P., Hiscott J., Razani B, Semenkovich CF, Chen X, Ting JP: The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity 2012, 36:933-46.
75. Tal MC, Sasai M, Lee H.K., Yordy B., Shadel GS, Iwasaki A: Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2770-5.
76. Jounai N, Takeshita F, Kobiyama K., Sawano A, Miyawaki A, Xin K., Ishii KJ, Kawai T, Akira S, Suzuki K., Okuda K: The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14050-5.
77. Tattoli I, Carneiro LA, Jéhanno M, Magalhaes J.G., Shu Y., Philpott DJ, Arnoult D, Girardin SE: NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO reports 2008, 9:293-300.
78. Abdul-Sater AA, Saïd-Sadier N, Lam VM, Singh B, Pettengill MA, Soares F, Tattoli I, Lipinski S, Girardin SE, Rosenstiel P, Ojcius DM: Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1. The Journal of biological chemistry 2010, 285:41637-45.
79. Cui J, Li Y, Zhu L., Liu D, Songyang Z, Wang H.Y., Wang R: NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nature immunology 2012, 13:387-95.
80. Jounai N, Kobiyama K, Shiina M., Ogata K, Ishii KJ, Takeshita F: NLRP4 negatively regulates autophagic processes through an association with beclin1. Journal of immunology (Baltimore, Md.: 1950) 2011, 186:1646-55.
81. Allen IC, TeKippe EM, Woodford R.T., Uronis JM, Holl EK, Rogers AB, Herfarth H.H., Jobin C., Ting JP: The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. The Journal of experimental medicine 2010, 207:1045-56.
82. Zaki MH, Boyd KL, Vogel P, Kastan M.B., Lamkanfi M., Kanneganti T: The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010, 32:379-91.
83. Dupaul-Chicoine J, Yeretssian G, Doiron K., Bergstrom, Kirk SB, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, Vallance BA, Saleh M: Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010, 32:367-78.
84. Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M., Kanneganti T: IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. Journal of immunology (Baltimore, Md.: 1950) 2010, 185:4912-20.
85. Salcedo R, Worschech A, Cardone M., Jones Y, Gyulai Z, Dai R., Wang E, Ma W, Haines D., O'hUigin C, Marincola FM, Trinchieri G: MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. The Journal of experimental medicine 2010, 207:1625-36.
86. Hu B, Elinav E, Huber S., Booth CJ, Strowig T, Jin C, Eisenbarth S.C., Flavell RA: Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:21635-40.
87. Hu B, Elinav E, Huber S., Strowig T, Hao L, Hafemann A., Jin C, Wunderlich C, Wunderlich T., Eisenbarth SC, Flavell RA: Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:9862-7.